sulfamethoxazole has been researched along with Acute Myelogenous Leukemia in 11 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a randomized, double-blind, placebo-controlled study to evaluate the efficacy of oral trimethoprim/sulfamethoxazole (TMP/SMX) in the prevention of bacterial infections in children with cancer." | 5.05 | Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children. ( Albo, VC; Kovatch, AL; Orlando, SJ; Phebus, CK; Prin, W; Shapiro, ED; Wald, ER; Wollman, MR, 1985) |
| "Continuous infusion of amikacin, cotrimoxazole and carbenicillin was the second empirically established combination of antibiotics used when fever occurred during the induction phase of chemotherapy in sixty-five patients (58 acute myeloid leukemias, 5 acute lymphoid leukemias, 2 non Hodgkin lymphomas)." | 3.66 | [An empirical combination of antibiotics used in aplasias during chemotherapy for acute malignant hemopathies (author's transl)]. ( Bryon, PA; Coiffier, B; Extra, JM; Ffrench, M; Fiere, D; Gonnaud, P; Guyotat, D; Imbert, C; Rebattu, P; Viala, JJ; Vuvan, H, 1982) |
| "The treatment of acute myelocytic leukemia in childhood and young adults has lagged behind that for acute lymphocytic leukemia." | 1.26 | The treatment of acute myelocytic leukemia in patients 30 years of age and younger. ( Brecher, M; Browman, G; Early, AP; Freeman, A; Preisler, HD; Raza, A; Walker, IR, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiere, D | 1 |
| Vuvan, H | 1 |
| Guyotat, D | 1 |
| Ffrench, M | 1 |
| Gonnaud, P | 1 |
| Extra, JM | 1 |
| Imbert, C | 1 |
| Coiffier, B | 1 |
| Bryon, PA | 1 |
| Rebattu, P | 1 |
| Viala, JJ | 1 |
| Pizzo, PA | 1 |
| Preisler, HD | 1 |
| Brecher, M | 1 |
| Browman, G | 1 |
| Early, AP | 1 |
| Walker, IR | 1 |
| Raza, A | 1 |
| Freeman, A | 1 |
| Fernández-Rañada, J | 1 |
| Vázquez, L | 1 |
| Escudero, A | 1 |
| Merino, JL | 1 |
| Gómez-Reino, F | 1 |
| Olmeda, F | 1 |
| Lahuerta, J | 1 |
| Larregla, S | 1 |
| Enno, A | 1 |
| Catovsky, D | 1 |
| Darrell, J | 1 |
| Goldman, JM | 1 |
| Hows, J | 1 |
| Galton, DA | 1 |
| Bateman, CJ | 1 |
| Rai, KR | 1 |
| Cuttner, J | 1 |
| Holland, JF | 1 |
| Davis, R | 1 |
| Mayer, R | 1 |
| McIntyre, OR | 1 |
| Preisler, H | 1 |
| Yates, J | 1 |
| Curtis, JE | 1 |
| Messner, HA | 1 |
| Minden, MD | 1 |
| Minkin, S | 1 |
| McCulloch, EA | 1 |
| Kovatch, AL | 1 |
| Wald, ER | 1 |
| Albo, VC | 1 |
| Prin, W | 1 |
| Orlando, SJ | 1 |
| Wollman, MR | 1 |
| Phebus, CK | 1 |
| Shapiro, ED | 1 |
| Spiers, AS | 1 |
| Tattersall, MH | 1 |
| Gaya, H | 1 |
| Toghill, PJ | 1 |
| Ryrie, DR | 1 |
| Tanna, MK | 1 |
| Tattersall, RB | 1 |
5 trials available for sulfamethoxazole and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
[Sulphatrimethoprim-nystatin combination in the prophylaxis of infection in acute leukaemia (author's transl)].
Topics: Bacterial Infections; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Humans; | 1980 |
Co-trimoxazole for prevention of infection in acute leukaemia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Clinical Trials as Topic; Colistin; Cross Infection; | 1978 |
Therapeutic strategies in acute myelocytic leukemia: a status report of the experience of CALGB. Cancer and Leukemia Group B.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; | 1987 |
High-dose cytosine arabinoside in the treatment of acute myelogenous leukemia: contributions to outcome of clinical and laboratory attributes.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation | 1987 |
Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children.
Topics: Adolescent; Anti-Infective Agents; Antineoplastic Agents; Bacterial Infections; Child; Child, Presch | 1985 |
6 other studies available for sulfamethoxazole and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
[An empirical combination of antibiotics used in aplasias during chemotherapy for acute malignant hemopathies (author's transl)].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Drug Combinations | 1982 |
Infectious complications in the child with cancer. III. Prevention.
Topics: Anti-Bacterial Agents; Child; Cross Infection; Filtration; Humans; Immunization; Immunization, Passi | 1981 |
The treatment of acute myelocytic leukemia in patients 30 years of age and younger.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Cytarabine; Daunorubicin; Doxorubicin; Drug C | 1982 |
Prophylactic co-trimoxazole in leukaemia.
Topics: Drug Combinations; Humans; Infection Control; Leukemia, Myeloid, Acute; Neutropenia; Sulfamethoxazol | 1978 |
Indications for systemic antibiotic prophylaxis in neutropenic patients.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Biguanides; Blood Cell Count; Carbenicillin; Cephalot | 1974 |
Induction of remission in myeloblastic and monoblastic leukaemia in adults with rubidomycin.
Topics: Adolescent; Adult; Aged; Alopecia; Ampicillin; Anemia, Aplastic; Antibiotics, Antineoplastic; Blood | 1971 |